https://www.selleckchem.com/pr....oducts/protokylol-hy
Background Older adults living with HIV (OALWH) are a growing population facing unique challenges to successful antiretroviral therapy.Objective To assess efficacy and safety profiles of antiretroviral regimens, including those containing dolutegravir, in OALWH.Methods Combined data from 6 phase III/IIIb trials in treatment-naive (ARIA, FLAMINGO, SINGLE, SPRING-2; N = 2634) and treatment-experienced (DAWNING, SAILING; N = 1339) participants receiving dolutegravir- or non-dolutegravir-based regimens were analyzed by age
Like
Comment
Share
